Aidarex Pharmaceuticals is recalling 97 bottles of Enalapril Maleate (2.5mg and 5mg), a blood pressure medication manufactured by Wockhardt Ltd. The recall was issued because the drug did not meet stability standards for a degradation byproduct called Enalapril Diketopiperazine during routine testing. Consumers should contact their healthcare provider or pharmacist regarding their medication, as using a product with out-of-specification degradation results may affect the drug's quality or safety.
The presence of degradation products exceeding approved limits means the medication may not maintain its intended chemical stability and quality over time. While the risk is categorized as low, impurities in prescription medications can potentially lead to reduced effectiveness or unintended side effects.
FDA Drug Recall Remedy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.